We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-0.58%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$742B
AUM Growth
-$15.7B
Cap. Flow
-$39.7M
Cap. Flow %
-0.01%
Top 10 Hldgs %
15.03%
Holding
8,301
New
450
Increased
3,451
Reduced
3,332
Closed
228

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$1.83B
2
RBLX icon
Roblox
RBLX
+$1.63B
3
BILL icon
BILL Holdings
BILL
+$1.46B
4
ABNB icon
Airbnb
ABNB
+$774M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$620M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.32B
2
SPOT icon
Spotify
SPOT
+$1.39B
3
OKTA icon
Okta
OKTA
+$1.24B
4
BABA icon
Alibaba
BABA
+$1.16B
5
AMZN icon
Amazon
AMZN
+$1.05B

Sector Composition

Rank Sector Weight
1 Technology 20.4%
2 Healthcare 9.82%
3 Financials 9.22%
4 Consumer Discretionary 8.85%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLN
5801
Silence Therapeutics
SLN
$504M
$218K ﹤0.01%
10,615
+1,050
+11% +$25.1K
TWN
5802
Taiwan Fund
TWN
$482M
$218K ﹤0.01%
6,184
-835
-12% -$30K
NBSE
5803
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$218K ﹤0.01%
3,012
-2,972
-50% -$227K
DFEB icon
5804
FT Vest US Equity Deep Buffer ETF February
DFEB
$463M
$217K ﹤0.01%
6,345
SLDB icon
5805
Solid Biosciences
SLDB
$790M
$217K ﹤0.01%
6,093
-6,656
-52% -$283K
DBTX
5806
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$217K ﹤0.01%
28,154
-47,233
-63% -$361K
INTA icon
5807
Intapp
INTA
$2.57B
$216K ﹤0.01%
8,369
+7,869
+1,574% +$256K
OVB icon
5808
Overlay Shares Core Bond ETF
OVB
$47M
$216K ﹤0.01%
+8,319
New +$219K
HZON
5809
DELISTED
Horizon Acquisition Corporation II
HZON
$216K ﹤0.01%
22,000
-159,057
-88% -$1.55M
SMIT
5810
DELISTED
Schmitt Industries Inc
SMIT
$216K ﹤0.01%
50,320
+800
+2% +$4.03K
MLNK
5811
DELISTED
MeridianLink
MLNK
$215K ﹤0.01%
+9,634
New +$238K
CPSS icon
5812
Consumer Portfolio Services
CPSS
$208M
$213K ﹤0.01%
36,673
-494
-1% -$2.6K
UBP
5813
DELISTED
Urstadt Biddle Properties Inc.
UBP
$211K ﹤0.01%
12,354
-60
-0.5% -$993
FDBC icon
5814
Fidelity D&D Bancorp
FDBC
$313M
$210K ﹤0.01%
4,153
-177
-4% -$9.3K
DHY
5815
Credit Suisse High Yield Credit Fund
DHY
$239M
$209K ﹤0.01%
84,340
-712,530
-89% -$1.79M
INZY
5816
DELISTED
Inozyme Pharma
INZY
$209K ﹤0.01%
17,994
-24,760
-58% -$386K
NEN icon
5817
New England Realty Associates
NEN
$196M
$209K ﹤0.01%
3,433
+1,400
+69% +$85.6K
WINA icon
5818
Winmark
WINA
$1.25B
$209K ﹤0.01%
970
-51
-5% -$10.5K
YTRA icon
5819
Yatra Online
YTRA
$54.9M
$209K ﹤0.01%
103,352
-3,600
-3% -$7.03K
ODC icon
5820
Oil-Dri
ODC
$1.41B
$208K ﹤0.01%
11,906
+64
+0.5% +$1.12K
CELC icon
5821
Celcuity
CELC
$4.28B
$207K ﹤0.01%
11,589
+5,859
+102% +$124K
CURE icon
5822
Direxion Daily Healthcare Bull 3X ETF
CURE
$171M
$207K ﹤0.01%
1,924
+1,351
+236% +$162K
RDVT icon
5823
Red Violet
RDVT
$968M
$207K ﹤0.01%
8,002
+7,103
+790% +$188K
QQQH
5824
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$378M
$207K ﹤0.01%
3,781
+1,881
+99% +$107K
TESS
5825
DELISTED
Tessco Technologies Inc
TESS
$207K ﹤0.01%
37,173
+5,317
+17% +$31.8K

Similar funds

Morgan Stanley's Q3 2021 Portfolio in Review

As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,332 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
  • Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
  • Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
  • Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
  • Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
  • Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
  • Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.

Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.